Published July 5, 2022 | Version v1
Journal article Open

Inhibidores de la Bomba de Protones y Riesgo de Cáncer Gástrico y Colorrectal

Authors/Creators

  • 1. FEA Aparato Digestivo. Hospital Universitario Puerta de Hierro Majadahonda, Madrid

Description

En un contexto de uso muy extendido y prolongado en la población de fármacos inhibidores de la bomba de protones, surge la necesidad de determinar los riesgos de su uso a largo plazo. Se presentan dos artículos, surgidos de la misma cohorte poblacional británica, que comparan el riesgo de cáncer gástrico y colorrectal entre pacientes usuarios de fármacos inhibidores de la bomba de protones y de fármacos antagonistas de los receptores H2 de la histamina.

 

In a context of widespread and prolonged use of proton pump inhibitor drugs in the population, there is a need to determine the risks of their long-term use. These are two articles from the same British population-based cohort, that compare the risk of gastric and colorectal cancer among patients who use proton pump inhibitor drugs and histamine H2 receptor antagonist drugs

Files

Inhibidores de la bomba de protones.pdf

Files (282.7 kB)

Name Size Download all
md5:a5c61a7728b5ba72870728e5377fbb0c
282.7 kB Preview Download

Additional details

References

  • Vol 93, Nº 2, Págs 240-246. 2018. Nehra AK, Alexander JA, Loftus CG, et al. Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc. Doi: http://dx.doi.org/10.1016/j.mayocp.2017.10.022
  • Vol 68, Nº 2, Págs 374-376. 2019. Peng Y-C, Huang L-R, Lin C-L, et al. Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD. Gut. Doi: http://dx.doi.org/10.1136/gutjnl-2018-316057
  • Vol 67, Nº 10, Págs 1908-1910. 2018. Niikura R, Hayakawa Y, Hirata Y, et al. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis. Gut. Doi: http://dx.doi.org/10.1136/gutjnl-2017-315710
  • Vol 7, Nº 10, Págs. 2017. Brusselaers N, Wahlin K, Engstrand L, et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. Doi: http://dx.doi.org/10.1136/bmjopen-2017-017739
  • Vol 100, Págs 1503-1507. 2019. Poulsen AH, Christensen S, McLaughlin JK, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. Doi: http://dx.doi.org/10.1038/sj.bjc.6605024
  • Vol. 31, Págs 675-684. 2008. Tamim H, Duranceau A, Chen L-Q, et al. Association between use of acidsuppressive drugs and risk of gastric cancer. A nested case-control study. Drug Saf. Doi: http://dx.doi.org/10.2165/00002018-200831080-00004
  • Vol 55, Nº 11, Págs 1538-1544. 2006. García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut. Doi: http://dx.doi.org/10.1136/gut.2005.086579
  • Vol 123, Págs 307-315. 2020. Liu P, McMenamin Úna C, Johnston BT, et al. Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies. Br J Cancer. Doi: http://dx.doi.org/10.1038/s41416-020-0860-4
  • Vol 115, Nº 5, Págs 705-715. 2020. Lee JK, Merchant SA, Schneider JL, et al. Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community-based population. Am J Gastroenterol. Doi: http://dx.doi.org/10.14309/ajg.0000000000000591
  • Vol 70, Nº 11, Págs 2066-2075. 2021. Seo SI, Park CH, You SC, et al. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut. Doi: http://dx.doi.org/10.1136/gutjnl-2020-323845
  • Vol 116, Nº 6, Págs 1211-1219. 2021. Shin G-Y, Park JM, Hong J, et al. Use of proton pump inhibitors vs histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study. Am J Gastroenterol. Doi: http://dx.doi.org/10.14309/ajg.0000000000001167
  • Vol 2, Nº 4, Págs 165-170. 2020. Kuiper JG, Herk-Sukel MPP, Lemmens VEPP, et al. Proton pump inhibitors are not associated with an increased risk of colorectal cancer. GastroHep. Doi: https://doi.org/10.1002/ygh2.409
  • Vol 12. 2017. Hwang IC, Chang J, Park SM. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: a Korean nationwide prospective cohort study. PLoS One. Doi: https://doi.org/10.1371/journal.pone.0189114
  • Vol 9, Nº 2, Págs 192-193. 2013. Lai S-W, Liao K-F, Lai H-C, et al. Use of proton pump inhibitors correlates with increased risk of colorectal cancer in Taiwan. Asia Pac J Clin Oncol
  • Vol 18, Nº 7, Págs 540-544. 2009. Chubak J, Boudreau DM, Rulyak SJ, et al. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. Doi: https://doi.org/10.1002/pds.1749
  • Vol 103, Nº 4, Págs 966-973. 2008. Van Soest EM, van Rossum LGM, Dieleman JP, et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol. Doi: http://dx.doi.org/10.1111/j.1572-0241.2007.01665.x
  • Vol 133, Nº 3, Págs 755-760. 2007. Robertson DJ, Larsson H, Friis S, et al. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology. Doi; https://doi.org/10.1053/j.gastro.2007.06.014
  • Vol 133, Nº 3, Págs 748-754. 2007. Yang Y-X, Hennessy S, Propert K, et al. Chronic proton pump inhibitor therapy and the risk of colorectal cancer. Gastroenterology. Doi: http://dx.doi.org/10.1053/j.gastro.2007.06.022
  • Vol 115, Nº 5, Págs 706-715. 2020. Lee JK, Merchant SA, Schneider JL, et al. Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community-based population. Am J Gastroenterol. Doi: http://dx.doi.org/10.14309/ajg.0000000000000591
  • Vol 123, Págs 844-851. 2020. Babic A, Zhang X, Morales-Oyarvide V, et al. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies. Br J Cancer. Doi: http://dx.doi.org/10.1038/s41416-020-0939-y
  • Vol 45, Nº 1, Pág 101397. 2021. Lei W-Y, Wang J-H, Yi C-H, et al. Association between use of proton pump inhibitors and colorectal cancer: a nationwide population-based study. Clin Res Hepatol Gastroenterol. Doi: https://doi.org/10.1016/j.clinre.2020.02.017